Drug Shortage Report for TARO-TEMOZOLOMIDE
| Report ID | 18102 |
| Drug Identification Number | 02443481 |
| Brand name | TARO-TEMOZOLOMIDE |
| Common or Proper name | TEMOZOLOMIDE |
| Company Name | TARO PHARMACEUTICALS INC |
| Market Status | MARKETED |
| Active Ingredient(s) | TEMOZOLOMIDE |
| Strength(s) | 20MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL |
| Packaging size | 20 blister |
| ATC code | L01AX |
| ATC description | ALKYLATINGAGENTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2017-08-02 |
| Estimated end date | 2017-10-09 |
| Actual end date | 2017-10-01 |
| Shortage status | Resolved |
| Updated date | 2017-10-02 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 130 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2017-10-02 | French | Compare |
| v6 | 2017-10-02 | English | Compare |
| v5 | 2017-09-08 | French | Compare |
| v4 | 2017-09-08 | English | Compare |
| v3 | 2017-08-03 | English | Compare |
| v2 | 2017-08-02 | French | Compare |
| v1 | 2017-08-02 | English | Compare |
Showing 1 to 7 of 7